Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Cartesian Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Cartesian Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Seven One Eight Three Four Irrevocable Trust | 10% Owner | 5,313,261Indirect | Apr 6, 2026 | 1 |
| Hoge Elizabeth | 10% Owner | 5,313,261Indirect | Apr 6, 2026 | 1 |
| Kalayoglu Murat | 10% Owner | 5,313,261Indirect | Apr 6, 2026 | 2 |
| Singer Michael | Director | 49,578 | Mar 13, 2026 | 3 |
| Brunn Carsten | President and CEO | 323,530 | Jan 8, 2026 | 2 |
| Davis Blaine | Chief Financial Officer | 121,220 | Jan 8, 2026 | 2 |
| Miljkovic Milos | Chief Medical Officer | 58,820 | Jan 8, 2026 | 2 |
| Springer Timothy A | Director, 10% Owner | 8,646,285 | Jan 6, 2026 | 1 |
| Zenner Patrick J | Director | 12,974 | Jan 6, 2026 | 1 |
| Barabe Timothy C | Director | 56,966 | Jan 6, 2026 | 2 |
| DeSilva Nishan M | Director | 11,366 | Jan 6, 2026 | 1 |
| Malik Kemal | Director | 11,133 | Jan 6, 2026 | 1 |
| English Emily | Chief Operations Officer | 94,226 | Jan 6, 2026 | 3 |
| Seymour June Ann | Chief Accounting Officer | 6,500 | Jan 6, 2026 | 2 |
| Bot Adrian Ion | Director | 5,800 | Dec 18, 2025 | 1 |
| Jewell Christopher M | Chief Scientific Officer | 62,490 | Jan 13, 2025 | 0 |
| Kurtoglu Metin | Chief Technology Officer | 62,258 | Jan 7, 2025 | 0 |
| Cox Carrie Smith | Director | 15,629 | Jan 6, 2025 | 0 |
| Sallin Aymeric | Director | 178,000 | Jan 4, 2024 | 0 |
| Myers Scott Dunseth | Director | – | Nov 15, 2023 | 0 |
| Traber Peter G | Chief Medical Officer | 451,826 | Sep 26, 2023 | 0 |
| Kishimoto Takashi Kei | Chief Scientific Officer | 225,316 | Jun 1, 2023 | 0 |
| Johnston Lloyd P. | Chief Operations Officer | 265,515 | Jan 6, 2023 | 0 |
| Ando Goran | Director | – | Jan 4, 2023 | 0 |
| Tan Kevin | Chief Financial Officer | 77,000 | Jan 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Jewell Christopher MChief Scientific Officer | SSale | −2.55K | $16.78 | −$42.8K | −4.6%53.5K after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Miljkovic MilosChief Medical Officer | SSale | −1.88K | $16.78 | −$31.5K | −5.0%35.4K after | 2 lots |
| Jan 7, 2025 (view filing) | Jan 3-6 | 4 days | Kurtoglu MetinChief Technology Officer | SSale | −4.88K | $16.78 | −$81.8K | −7.3%62.3K after | 2 lots |
| Jan 15, 2025 (view filing) | Jan 13-14 | 2 days | Springer Timothy ADirector, 10% Owner | PPurchase | +21.0K | $17.47 | +$366.4K | +0.2%8.53M after | 3 lots |
| Mar 20, 2025 (view filing) | Mar 18-20 | 2 days | Springer Timothy ADirector, 10% Owner | PPurchase | +89.9K | $15.26 | +$1.37M | +1.1%8.62M after | 3 lots |
| Apr 11, 2025 (view filing) | Apr 9-11 | 2 days | Springer Timothy ADirector, 10% Owner | PPurchase | +22.4K | $10.21 | +$228.3K | +0.3%8.64M after | 5 lots |
| Apr 11, 2025 (view filing) | Apr 9-11 | 2 days | Springer Timothy ADirector, 10% Owner | PPurchase | +126.7K | $10.21 | +$1.29M | +23.9%656.5K after | 5 lots |
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Barabe Timothy CDirector | PPurchase | +30.0K | $6.86 | +$205.8K | +123.1%54.4K after | |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Davis BlaineChief Financial Officer | SSale | −10.6K | $6.82 | −$72.2K | −8.0%121.2K after | |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Miljkovic MilosChief Medical Officer | SSale | −3.57K | $6.82 | −$24.4K | −5.7%58.8K after | |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Brunn CarstenPresident and CEO | SSale | −23.8K | $6.82 | −$162.1K | −6.8%323.5K after |